These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The sympathetic nervous system and hypertension: mechanisms and treatment. Weber MA Clin Auton Res; 1993 Dec; 3(6):397-8. PubMed ID: 8193528 [No Abstract] [Full Text] [Related]
25. Transdermal clonidine therapy in elderly mild hypertensives: effects on blood pressure, plasma norepinephrine and fasting plasma glucose. Klein C; Morton N; Kelley S; Metz S J Hypertens Suppl; 1985 Dec; 3(4):S81-4. PubMed ID: 3868715 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the pharmacokinetics, pharmacodynamics, and safety of oral (Catapres) and transdermal (M-5041T) clonidine in healthy subjects. Fujimura A; Ebihara A; Ohashi K; Shiga T; Kumagai Y; Nakashima H; Kotegawa T J Clin Pharmacol; 1994 Mar; 34(3):260-5. PubMed ID: 8021335 [TBL] [Abstract][Full Text] [Related]
28. Effects of transdermal clonidine treatment on withdrawal symptoms associated with smoking cessation. A randomized, controlled trial. Ornish SA; Zisook S; McAdams LA Arch Intern Med; 1988 Sep; 148(9):2027-31. PubMed ID: 3046542 [TBL] [Abstract][Full Text] [Related]
29. Clonidine hydrochloride (catapres) in the management of hypertension. Datey KK; Bhagat SJ; Goyal BK; Mishra SJ; Kapadia NM; Rajlaxmi BN Indian J Chest Dis; 1975 Oct; 17(4):158-65. PubMed ID: 1218938 [No Abstract] [Full Text] [Related]
30. Transdermal clonidine in the treatment of adolescent hypertension. Falkner B; Thanki B; Lowenthal DT J Hypertens Suppl; 1985 Dec; 3(4):S61-3. PubMed ID: 3868713 [TBL] [Abstract][Full Text] [Related]
31. [Clonidine transdermal therapeutic system in essential hypertension: effect and tolerance]. Groth H; Vetter H; Knüsel J; Boerlin HJ; Walger P; Baumgart P; Wehling M; Siegenthaler W; Vetter W Schweiz Med Wochenschr; 1983 Dec; 113(49):1841-5. PubMed ID: 6676936 [TBL] [Abstract][Full Text] [Related]
32. [Mechanisms of cutaneous accidents related to non-steroidal anti-inflammatory agents]. Abensour M; Grosshans E Therapie; 1988; 43(6):469-73. PubMed ID: 2976215 [No Abstract] [Full Text] [Related]
33. Management of acute hypertensive crises with clonidine (Catapres). Anavekar SN; Johnston CI Med J Aust; 1974 May; 1(21):829-31. PubMed ID: 4853087 [No Abstract] [Full Text] [Related]
34. [Hypotensive response to parenteral administration of clonidine in hypertensive patients]. Reyes AJ; Acosta Barrios T Rev Esp Cardiol; 1973; 26(2):129-38. PubMed ID: 4720292 [No Abstract] [Full Text] [Related]
35. Transdermal clonidine for the treatment of essential hypertension. McChesney JA; Ryan C; Shaw RE; Fishman-Rosen J; Murphy MC Compr Ther; 1987 Apr; 13(4):49-53. PubMed ID: 3568603 [No Abstract] [Full Text] [Related]
36. [Low-dose clonidine in moderate arterial hypertension]. Román O; Gac JC; Sudy E; Valenzuela MA Rev Med Chil; 1987 Sep; 115(9):847-51. PubMed ID: 3333445 [No Abstract] [Full Text] [Related]
37. Old wine into new bottles. A critical evaluation of transdermal clonidine in the treatment of hypertension. Mathias CJ Clin Auton Res; 1993 Dec; 3(6):355. PubMed ID: 8193520 [No Abstract] [Full Text] [Related]
38. Transdermal clonidine for hypertension. Med Lett Drugs Ther; 1985 Oct; 27(700):95-6. PubMed ID: 4058369 [No Abstract] [Full Text] [Related]
39. Thioridazine withdrawal-induced behavioral deterioration treated with clonidine: two case reports. Sovner R Ment Retard; 1995 Aug; 33(4):221-5. PubMed ID: 7565144 [TBL] [Abstract][Full Text] [Related]
40. Intravenous clonidine in severe hypertension. Sinha RS; Hasan M; Ahuja RC; Bhargava KP J Assoc Physicians India; 1983 Dec; 31(12):775-7. PubMed ID: 6370950 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]